granted
on 06 Feb 2024
Last Applicant/ Owned by
3675 Market Street, Suite 200
Philadelphia
PA
19104
Serial Number
97510062 filed on 19th Jul 2022
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
"BIOTHERAPEUTICS"
Scientific research and development services in the nature of platform technology, namely, development of immunotherapy platforms for the creation of CAR T-cells "BIOTHERAPEUTICS" The English translation of VITTORIA in the mark is VICTORY. Color is not claimed as a feature of the mark. pharmaceuticals and medical preparations for immunotherapy, cell therapy, immune cell therapy, and T-cell theRead More
Scientific research and development services in the nature of platform technology, namely, development of immunotherapy platforms for the creation of CAR T-cells
pharmaceuticals and medical preparations for immunotherapy, cell therapy, immune cell therapy, and T-cell therapy for use in the prevention and treatment of cancer, tumors, and diseases and disorders of the immune system
No 97510062
No Service Mark
No 152764374909
No
No
No
No
No
No
No
No
The mark consists of the wording "VITTORIA BIOTHERAPEUTICS" with the letter V appearing in a stylized form. Biotherapeutics is positioned below Vittoria.
| Status Date | Action Taken |
|---|---|
| 08th Feb 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 06th Feb 2024 | SOU TEAS EXTENSION RECEIVED |
| 06th Feb 2024 | SOU EXTENSION 1 FILED |
| 06th Feb 2024 | SOU EXTENSION 1 GRANTED |
| 15th Aug 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 20th Jun 2023 | PUBLISHED FOR OPPOSITION |
| 20th Jun 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 31st May 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 17th May 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 02th May 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
